BLOG

OncoCyte Spells Out the Acquisition Plan for Razor Genomics

OncoCyte’s newly appointed CEO Ronald Andrews is making good on a promise for more transparency in the company. Investors and analysts witnessed this new level of transparency first hand during a detailed conference call the Alameda, CA-based company held concerning its plan for acquiring Razor Genomics.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}